Menu
Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 15
Review
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,146 | Dovepress* | 5,498+ | 267 | 5,765 | |
| PubMed Central* | 2,648 | 698 | 3,346 | ||
| Totals | 8,146 | 965 | 9,111 | ||
| *Since 16 August 2022 | |||||
View citations on PubMed Central and Google Scholar